Outlook Therapeutics (OTLK) Return on Equity (2016 - 2026)
Outlook Therapeutics (OTLK) reported Return on Equity of 0.02% for Q1 2026, up 1.0% year-over-year from 0.02% in Q1 2025, and down 42.32% quarter-over-quarter from 0.03% in Q4 2025.
Outlook Therapeutics (OTLK) Return on Equity (2016 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 11 years of Return on Equity data on file, last reported at 0.02% in Q1 2026.
- Return on Equity for Q1 2026 came in at 0.02%, up 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02% (up 1.0% YoY), and the FY2025 annual result was 0.01%, down 1.0% from the prior year.
- Return on Equity declined to 0.02% in Q1 2026 per OTLK's latest filing, from 0.03% in the prior quarter.
- Over five years, Return on Equity peaked at 0.06% in Q3 2023 and troughed at 0.23% in Q2 2023.
- A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Equity.
- The sharpest annual moves came in 2023 and 2024: Return on Equity decreased 21 bps in 2023, then rose 24 bps in 2024.
- A 5-year view of Return on Equity shows it stood at 0.05% in 2022, then surged by 148 bps to 0.03% in 2023, then plunged by 47 bps to 0.01% in 2024, then surged by 90 bps to 0.03% in 2025, then plunged by 42 bps to 0.02% in 2026.
- Business Quant data shows OTLK's Return on Equity at 0.02% in Q1 2026, 0.03% in Q4 2025, and 0.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -0.81% |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -0.04% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -0.01% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.01% |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | 0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.02% |
| Dec 31, 2025 | 0.03% |
| Sep 30, 2025 | 0.03% |
| Jun 30, 2025 | 0.02% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.01% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | 0.02% |
| Dec 31, 2023 | 0.03% |
| Sep 30, 2023 | 0.06% |
| Jun 30, 2023 | -0.23% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.05% |
| Sep 30, 2022 | -0.04% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.06% |
| Jun 30, 2021 | -0.03% |